Filing Details
- Accession Number:
- 0001567619-22-020920
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-11-28 16:30:50
- Reporting Period:
- 2022-11-18
- Accepted Time:
- 2022-11-28 16:30:50
- Original Submission Date:
- 2022-11-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385818 | Aytu Biopharma Inc | AYTU | Pharmaceutical Preparations (2834) | 470883144 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491847 | K Mark Oki | C/O Aytu Biopharma, Inc. 373 Inverness Parkway, Suite 206 Englewood CO 80112 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-11-18 | 90,000 | $0.23 | 190,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
